CAV1 and breast cancer: This may be possible, since results from our laboratory provide evidence indicating that CAV1-containing EVs from breast cancer cells are enriched in cell adhesion-related proteins, such as cysteine-rich angiogenic inducer 61 (Cyr61), S100A9, and tenascin [122].